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AbstrACt
Objectives Given the difficulties in diagnosing and 
treating head- and- neck cancer, care is centralised in the 
Netherlands in eight head- and- neck cancer centres and 
six satellite regional hospitals as preferred partners. A 
requirement is that all patients of the partner should be 
discussed in a multidisciplinary team meeting (MDT) with 
the head- and- neck centre as part of a Dutch health policy 
rule. In this mixed- method study, we evaluate the value 
that the video- conferenced MDT adds to the MDTs in the 
care pathway, quantitative regarding recommendations 
given and qualitative in terms of benefits for the teams and 
the patient.
Design A sequential mixed- method study.
setting One oncology centre and its partner in the 
Northern part of the Netherlands.
Participants Head- and- neck cancer specialists 
presenting patient cases during video- conferenced MDT 
over a period of 6 months. Semistructured interviews held 
with six medical specialists, three from the centre and 
three from the partner.
Primary and secondary outcome measures Percentage 
of cases in which recommendations were given on 
diagnostic and/or therapeutic plans during video- 
conferenced MDT.
results In eight of the 336 patient cases presented (2%), 
specialists offered recommendations to the collaborating 
team (three given from centre to partner and five from 
partner to centre). Recommendations mainly consisted 
of alternative diagnostic modalities or treatment plans 
for a specific patient. Interviews revealed that specialists 
perceive added value in discussing complex cases 
because the other team offered a fresh perspective by 
hearing the case ‘as new’. The teams recognise the 
importance of keeping their medical viewpoints aligned, 
but the requirement (that the partner should discuss all 
patients) was seen as outdated.
Conclusions The added value of the video- conferenced 
MDT is small considering patient care, but the specialists 
recognised that it is important to keep their medical 
viewpoints aligned and that their patients benefit from the 
discussions on complex cases.
IntrODuCtIOn
Most tumours in the head or neck region 
(nasal cavity, paranasal sinuses, lips, mouth, 
salivary glands, throat or larynx and complex 
skin malignancies) are fast growing tumours.1 
This implies that a long interval between 
the moment of referral and the start of the 
primary treatment (surgery, radiotherapy 
and/or chemotherapy) can lead to tumour 
progression with less survival chance.2 
Because of complexity of diagnostic proce-
dures and therapeutic modalities and low 
volume of patients, head- and- neck cancer 
care is centralised in multidisciplinary head- 
and- neck cancer centres.3 In 1984, the Dutch 
Head & Neck Society (DHNS) was founded 
strengths and limitations of this study
 ► The study evaluates in depth the video- conferenced 
multidisciplinary team meeting (MDT) between the 
centre and the partner in the head- and- neck on-
cology care pathway and refocuses on benefits and 
drawbacks (strength).
 ► Participating specialists from different specialisms 
and locations were interviewed and identified ben-
efits and drawbacks of the video conference meet-
ings (strength).
 ► The researcher’s presence during video- conferenced 
MDT may have influenced the communication 
between the centre and the partner, also called 
‘Hawthorne effect’ (limitation).
 ► Only one of the six centres and its preferred partner 
in the Netherlands was studied (limitation).
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as a scientific organisation. Later, the DHNS became 
involved in the nationwide organisation of head- and- neck 
cancer care. As a result, since 1993, patients of head- and- 
neck cancer in the Netherlands are treated in eight head- 
and- neck cancer centres recognised by the DHNS; six 
centres have preferred partners.4 Within each head- and- 
neck cancer centre, multidisciplinary meetings according 
to national evidence- based guidelines are mandatory to 
provide the best diagnostic workup and treatment for 
patients and to sustain the quality of care in the oncology 
centres.5–8 Criteria for qualifying as centre are: having 
the specialisms with expertise to treat the tumour, having 
the necessary diagnostic and therapeutic facilities and 
treating at least 200 new patients each year. Partners fulfil 
the same criteria but should treat at least 80 new patients.
In 1997, after an informal collaboration period of 
4 years, the Medical Centre Leeuwarden became the 
formal preferred partner of the Head- and- Neck Cancer 
Centre of the University Medical Centre Groningen,9 
further referred to as the ‘partner’ and the ‘centre’. The 
collaboration of a centre with its partner is based on 
trust and sustainable agreements on governance aspects, 
evidence- based multidisciplinary decision- making and 
use of facilities.10–12 The collaboration consists of weekly 
multidisciplinary team meetings (MDTs) between centre 
and partner to discuss diagnostic and therapeutic plans. 
The efficiency of the MDTs is important for decision- 
making and care pathway management. The centre’s 
MDT regarding diagnostics and treatment involves more 
than nine disciplines (details presented elsewhere).13 
The teams of centre and partner meet face- to- face three 
times a year, where governance, guidelines and research 
projects are discussed.
The DHNS and the Dutch Health Care Inspectorate 
(DHCI) require that all new patients of the partner are 
discussed in a weekly MDT with the centre.14 This DHCI 
requirement can be seen as quality control over the 
partner clinic. Specialists from centre and partner, from 
the departments of oral and maxillofacial surgery (OMS), 
ear, nose and throat (ENT) and radiotherapy (RT) partic-
ipate. This weekly MDT is additional to a local MDT in 
the hospital where the patient is first seen and will be 
treated. Initially, these collaborative multidisciplinary 
weekly meetings were in the centre: three specialists trav-
elled to the oncology centre (2 hours travelling time and 
2 hours MDT). When videoconferencing became avail-
able, it became the preferred method for this commu-
nication.15 16 The video- conferenced MDT is scheduled 
after the local MDT. During the videoconferencing, the 
partner presents all patient cases, including available 
imaging, and proposed diagnostic and therapeutic plan. 
The centre presents complex cases or cases interesting 
to discuss. Both sides are free to offer recommendations. 
The team presenting the patient case is responsible 
for documenting changes when a recommendation is 
implemented.
Recommendations from both teams to the decision- 
making regarding diagnostic and therapeutic plans may 
add value to the quality of patient care.17 18 We decided to 
evaluate the video- conferenced MDT as part of the collab-
oration agreements because it was time consuming and 
there was a wish to refocus on benefits and drawbacks.
research question
The aim of this study was to analyse the value of video- 
conferenced MDT in the treatment of head- and- neck 
cancer patients in the care pathways, resulting in two 
questions.
1. How often are recommendations given on diagnostic 
and/or therapeutic plans by the teams during video- 
conferenced MDT?
2. What benefits and drawbacks of the video conference 
are perceived by the specialists in the teams?
DesIgn
This mixed- method study19–21 had a quantitative part 
followed by a qualitative part. The primary outcome of 
the weekly video- conferenced MDT was the percentage 
of cases in which recommendations on diagnostic and/or 
treatment plans were given. The secondary outcome were 
the benefits or drawbacks of the MDT video conference 
perceived/experienced by the participating specialists. 
In the study period, the teams acted conform the DHCI 
requirement that all patients of the partner should be 
presented in a multidisciplinary meeting with the centre.
Videoconferencing equipment used
The video- conferenced MDT was held in dedicated multi-
disciplinary meeting rooms, where screens can be oper-
ated with two to four computers with monitors. While 
the patient data are presented on the first screen, teams 
can see each other on the second screen. The videocon-
ferencing is operated via the ‘Webex’ application and a 
camera. Both locations call into a special safe ‘chat room’.
Centre: dedicated 20- seat videoconferencing room with 
three screens—beamers (software/provider Kinly; band-
width 2 Mbps) and five camera inputs. Four computer 
stations, one dedicated for radiology showing Picture 
Archiving and Communication System (PACS) imaging.
Partner: dedicated 10- seat videoconferencing room 
with one screen with possibility to see patient data and 
the other team; one computer log- on to patient dossiers 
showing data and imaging.
Patient data
Data of all patients presented by one of the teams during 
the video- conferenced MDT video conferences between 
September 2016 and February 2017 were included. The 
tumour localisation, histology and tumour stage were 
registered for all patients that were presented.
Patient involvement in study design
Patients were not involved in the study because the main 
purpose of the study was to evaluate the added value of 
the DHCI requirement in a weekly video- conferenced 
MDT.
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Table 1A Definitions of change impact and case complexity: operational definitions of major and minor changes in diagnostic 
or treatment plan
Diagnostic plan Treatment plan Remarks
Minor Additional more- detailed MRI or CT 
thorax of the area already imaged
Logistic change
Major Additional MRI or CT thorax in a 
different area from the area already 
imaged
Change in modality: adding or deleting 
a therapeutic modality; surgery 
radiotherapy or chemotherapy
Criterion Addition of diagnostic plan in a different 
area than already investigated
Adding or deleting a treatment modality 
from the treatment plan in the proposed 
or in a different area
After the major/minor 
decision is made, the 
decision registered in the 
research form will be verified 
by both specialists (giver and 
receiver)
Table 1B Definitions of change impact and case complexity: operational definition of case complexity
Modality Guideline Comorbidity
Not complex Unimodal treatment Diagnosis and treatment follows 
guideline
No comorbidity
Complex Multimodal treatment Diagnosis and/or treatment does not 
follow guideline
Comorbidity
Remarks  ► Unimodal: surgical procedure chemotherapy 
primary radiotherapy
 ► Multimodal: reconstruction surgery 
chemoradiotherapy or bioradiotherapy
Which guidelines are followed   
Quantitative part
Sample size calculation recommendations
In a 4- week pilot study of 4 sessions including 46 cases, 
carried out 9 months before study start, we found that in 
approximately 20% of cases a recommendation was given. 
To estimate this percentage with a 10% precision (95% 
CI: 15.5% to 25.4%) would require 250 cases. On average, 
15 cases were discussed at each weekly video- conferenced 
MDT. We estimated that 6 months would be sufficient to 
acquire the necessary 250 cases. The pilot study was also 
used to operationalise the primary outcome measure.
Recommendation registration
Recommendations were registered with the relevant data 
from electronic and written medical records on a clinical 
registration form by LSvH during the video conference. 
Each recommendation was assessed by the two teams with 
respect to change impact (minor or major; table 1A) on 
the diagnostic and/or therapeutic plan, case complexity, 
use of national multidisciplinary guidelines for the diag-
nostic and/or treatment plan and comorbidity of the 
patient (table 1B). LSvH registered the given recommen-
dation with the relevant data; JGAMdV and JR verified 
the registrations. During the videoconferencing sessions, 
field notes were taken by LSvH.
Statistical analysis
Differences in age, gender, tumour localisation and 
tumour histology (International Classification of Deseases 
in Oncology, ICD(O))22 and tumour stage between 
cases presented by the centre and those presented by 
the partner were analysed using t- test for independent 
samples, χ2 test and χ2 test exact procedure if require-
ments for the χ2 test were not met. Statistical analyses 
were performed using SPSS V.23.0 for Windows software. 
In all analyses, statistical significance was set at the 5% 
level.
Qualitative part
Interviews
Semistructured interviews were conducted with six 
medical specialists that attended the meetings most 
frequently, one from the OMS, ENT and RT depart-
ment of each team, to explore the added value of the 
video- conferenced MDT. The field notes taken by the 
researcher during the video- conferenced MDT were used 
to develop the questions for the semistructured inter-
views. After receiving verbal informed consent from the 
specialists, the semistructured interviews started with 
providing information about the recommendations given. 
Thereafter, it continued with the open question ‘What do 
you think is the value of the video conference between 
the head- and- neck cancer centre and their preferred 
partner?’. LSvH then guided the interview using a short 
topic list including ‘added value’ and ‘perceived possibili-
ties for change or improvement in the video- conferenced 
MDT’ (table 2). The different topics were introduced in 
a flexible way, and the interviews took the form of natural 
conversations.
Interviews lasted between 25 and 40 min, were audio 
recorded and transcripts of the interviews were made. 
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Table 2 Interview guide
Topics Questions
Added- value videoconferencing What do you think is the added value of the video- conferenced MDT between the head- 
and- neck cancer centre (centre) and their preferred partner (partner)?
Could you mention strong points of the video- conferenced MDT?
Could you give examples?
Could you name points for improvement?
Could you mention examples?
Role of specialism in video 
conference
What do you think the role of a specialist is in the video- conferenced MDT between 
centre and partner?
The consultation is required by the Dutch Head and Neck Society and the Dutch Health 
Care Inspectorate, how usefulness do you think it is?
Would you advise stopping the consultation if it was not mandatory?
Results interpretation Have you given recommendations to the centre/partner?
Have you received recommendations from the centre/partner?
Could you indicate what the difference is between peer consultation and giving a 
recommendation?
What do you think would be an ideal video- conferenced MDT? Could you explain your 
answer?
What do you think could be adjusted in the video- conferenced MDT to make the 
consultation more effective and more efficient?
The participants were asked to review the transcripts 
and extracted quotes, related to perceived added value, 
possible improvements and the role of a specialist in the 
video- conferenced MDT.
Thematic analysis
Quotes were anonymised and coded for their relevance 
to possible benefits or drawbacks for the collaboration 
between the teams and for patient care. The first stage 
of this inductive analysis of the interviews involved two 
authors, JR and JGMvdH, in an initial open coding proce-
dure that resulted in a list of codes corresponding closely 
to the text fragments extracted from the six interviews. 
The codes were placed in a coding tree using a thematic 
analysis approach with main themes recommendations, 
added value, collaboration and planning.23 24 Codes were 
judged as being a benefit or a drawback. Any disagree-
ments during the coding were discussed between the 
coders and the researcher.25 After the preliminary 
results were collated, for credibility a member check was 
performed with participants.26 The Clinical Research 
Office performed a planned quality check on data 
management.
results
Quantitative analysis
From September 2016 to February 2017, 82 patients 
were presented by the centre and 177 by the partner 
in 18 weekly video- conferenced MDTs (table 3). In this 
period of 22 weeks, three meetings were cancelled due 
to a ‘medical complication meeting’, a technical problem 
to connect and a holiday recess. Further, the researcher 
could not attend one session.
Most of the centre’s patients (71 out of 82—86%) were 
presented only once, nine were presented twice (11%), 
one patient was discussed three times and another four 
times. Whereas 111 patients were presented only once 
(63%) by the partner. Generally, patients of the partner 
where presented twice or three times: the first time their 
diagnostic plan, the second time the therapeutic plan 
and sometimes surgical results the third time (55 out of 
177—31%). Only one patient was discussed four times; 
five patients on the partner’s list were not discussed at the 
first opportunity because imaging was not complete.
The partner presented significantly (p<0.001) more 
cases with infections that were initially suspected malig-
nancy, T1- stage patients and non- complex cases. Tumour 
localisation and histology differed also significantly 
between centre and partner (table 3). In 61% of the 18 
video conferences, both teams were complete; the centre 
team was not complete in 22% (n=4) and, in 17% (n=3), 
the partner team was not complete. On those occasions 
one of the other specialisms would present the cases, for 
example, OMS for ENT. The centre’s ENT department 
was represented in most meetings by an ENT specialist 
training to be a head- and- neck oncology surgeon. The 
centre presented on average 5.2 (SD 2.4) cases per video 
conference, the partner presented on average 13.5 (SD 
3.9) cases.
recommendations given
Recommendations were given in 8 of the 336 cases 
presented (2%; 95% CI: 1% to 5%) relating to 8 of the 
259 patients (3%; 95% CI: 1% to 6%).
Of these recommendations, five were major and three 
minor (table 4). Four recommendations concerned 
diagnostic plans and four treatment plans. On three of 
the eight occasions when a recommendation was given, 
the centre’s team was incomplete with one of the three 
specialisms absent. Seven of the eight recommendations 
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Table 3 Patients and their tumour characteristics, as presented during video conference meetings
Number of patients (total n=259) Centre (n=82) Partner (n=177)
Statistics, p value(n=number of available data) Mean SD Mean SD
Age (mean, SD) 67.8 15.2 66.7 16.1 (t- test) 0.533
Gender (n=259) n % n % (χ2) 0.394
  Female 27 10 68 26
Tumour localisation (n=206)* n % n % (χ2 exact)<0.001
Lip (C00) 3 3 4 2
Oral cavity 21 23 29 12
  Tongue (C01, C02) 6 – 11 –
  Gums (C03) 5 – 7 –
  Floor of mouth (C04) 4 – 4 –
  Oral cavity, unspecified (C05, C06, C14) 6 – 7 –
Major salivary glands (C07, C08) 2 2 7 3
Oropharynx (C09,C10) 7 8 6 2
Nasopharynx (C11) 0 0 0 0
Nasal cavity (C30) 2 2 3 1
Hypopharynx (C12, C13) 5 5 5 2
Sinus (C31) 3 3 3 1
Larynx (C32) 10 11 15 6
Bronchus and lung (C34) 0 0 5 2
Haematological and reticuloendothelial systems (C42) 0 0 11 5
Skin (C44) 14 15 35 14
Lymph nodes (C77) 2 2 1 0
Unknown (C80) 3 3 0 0
Miscellaneous (C20, 33, 41, 49, 50, 64, 73) 3 3 7 3
Unknown (C80) 3 3 0 0
Morphology or cell type (n=259) n % n % (χ2)<0.001
  Squamous cell carcinoma 57 72 78 44
  Basic cell carcinoma 3 4 6 3
  Melanoma 0 0 11 6
  Miscellaneous malignant 7 9 9 5
  Benign 2 2 18 10
  Infection—premalignant abnormalities 2 2 12 7
  Miscellaneous 11 13 43 24
T- stage (n=159)† n % n % (χ2)<0.001
  T1 13 14 42 17
  T2 20 22 20 8
  T3 8 9 9 4
  T4 25 27 14 6
  Tx 7 8 1 1
In total 336 cases presented: 93 by centre and 243 by partner.
*Only tumour localisation if tumour diagnosed.
†Only TNM code if first diagnosed, so there are more patients in which ‘localisation’ is known (ie, for relapse or tumour residue or metastases).
were given by OMS specialists, and five of the eight were 
related to ENT patients. Seven of the eight instances 
occurred on a patient’s first presentation and the other 
one during a second presentation although, in this case, 
the imaging had not been complete the first time. In 
general, recommendations were given related to the 
more complex cases, but not necessarily patients with 
comorbidity or those with more advanced tumours. 
About 70% of case were ‘formalities’ or ‘routine patients’, 
meaning patients that fitting the guidelines (well- defined 
tumours with limited regional metastases and without 
comorbidity).
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Qualitative analysis—specialist interviews
During May 2017, six interviews were held. From the 
transcripts of the 6 interviews, 107 quotes were regis-
tered. During the coding procedure, items were placed 
in a coding tree with relevance to the primary research 
question (recommendations given) and the secondary 
research question (perceived benefits and drawbacks) 
by the researcher in consultation with the coders. For 
each major theme, minor themes were derived from the 
researcher’s field notes. In total, 282 scores were given 
(table 5). In several instances, the quotes were scored 
differently although the intercoder agreement was 
acceptable given the possible 37 codes to choose from.
Benefits were more frequently mentioned by special-
ists of the partner, and the drawbacks more frequently by 
specialists of the centre. But the majority of codes had 
a positive connotation for the video- conferenced MDT 
(table 5).
Six main items were important according to the special-
ists (quotes in italic).
1. The video conference adds value when discussing 
complex cases, through assisting in fine tuning and 
aligning medical procedures (code 1, 20×).
A patient is presented about which the own team had 
some discussion that can be discussed with the part-
ner. In that manner, you get a confirmation or advice 
to change your treatment plan. This advice can be 
given by the same specialism but also by other mem-
bers of the head- and- neck oncology team (ENT).
2. Communication is essential for cooperation between 
teams (code 2, 10×); furthermore, it is important to know 
the partner well, not only via videoconferencing (code 
13, 15×), and to interact respectfully (code 5, 10×) with 
mutual trust (code 7, 9×).
 The most important feature of the video- conferenced 
MDT is to communicate with each other on substan-
tive medical matters, to be on speaking terms, and to 
know each other (RT).
During the videoconferencing, we respect each oth-
er, we listen to each other and we are open to each 
other’s additional comments. We trust each other as 
partners (OMS).
3. Recommendations are suggested alternatives on 
diagnostic modalities and treatment plans for specific 
patients (code 14, 17×).
 The video- conferenced MDT has the character of 
a collegial discussion, in which in collaboration the 
best diagnostic or treatment plan for your patient is 
reached. Confirmation on your treatment plan adds 
value too (OMS).
4. For routine cases that fall within guideline for treat-
ment, the video conference meeting adds little value as 
for changes in medical content, it can even irritate the 
participants in such cases (code 15, 9×).
 The video- conferenced MDT sometimes changes the 
treatment plan for an individual patient. The video 
conference is not the meeting where new procedures 
or guidelines are developed (RT).
5. There is a wish to integrate the video conference with 
the site multidisciplinary meeting in both hospitals, the 
centre and the partner (code 17, 12×).
 Integration of the two local multidisciplinary meet-
ings with the video- conferenced MDT could be valu-
able (ENT).
6. The DHCI requirement (discuss all the partner’s 
cases) has no added value. It is seen as old- fashioned or 
outdated (code 29, 8×).
It is better to prepare at a high level and discuss, than 
to present all the patients and deal with each one 
briefly. Mutual preparation on special request could 
have added value, for example, a literature search on 
a complex osteosarcoma case (OMS).
DIsCussIOn
Our results show that the added value of the weekly video- 
conferenced MDT between the head- and- neck cancer 
centre and the partner hospital was small given the few 
recommendations made on the initial diagnostic and/
or treatment plan. Nevertheless, the specialists from 
both sites recognised the importance of keeping their 
medical viewpoints aligned through this type of commu-
nication. Whenever discussing complex cases in which 
a major change was recommended (in five of the eight 
recommendations), for example, to change the surgical 
approach to save functionality of organs or tissue, the 
recommended change in treatment had a large impact 
for that patient (table 4).
The data from the interviews suggest that especially 
complex patients would benefit from intercollegial 
consultation via video- conferenced MDT. If the teams 
were not obliged to discuss so many routine cases, they 
could use the time saved to prepare and discuss complex 
cases in greater depth.27 The specialists said that they did 
not want to stop the video- conferenced MDT, because 
they appreciate reflecting on diagnostic and treatment 
plans with trusted expert colleagues.
Because of an increase in patients to be presented in the 
meeting, we were looking for a more efficient meeting, 
which could be reached not discussing the ‘formalities’ 
or ‘routine patients’ (about 70% of patients); developing 
an evidence- based working method would need more 
research. This result is supported by a large survey in 
the UK after 10 years of use of an MDT format, where 
specialists also said they wanted to change many compo-
nents and refocus to spend more time on complex cases 
in detail.18
The qualitative part of this study showed that medical 
specialists perceived added value in discussing complex 
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cases in a collegiate consultation, because the other team 
offers a fresh perspective by hearing the case ‘as new’. 
Although remarks were often about nuances, the confir-
mation on the chosen treatment by the other team was 
experienced as helpful. This view is supported in litera-
ture where medical specialists found videoconferencing 
useful in at least one aspect of their practice.10
An important requirement to communicate through 
video conference is that participants know each other 
from personal meetings to support mutual trust and 
respect as the basis for cooperation. The finding that 
collaboration and cooperation improves when each disci-
pline understands each other’s roles and that specialties 
working together for a long time do not need many words 
to come to a decision was supported previously.17 28
The video- conferenced MDT can be used to introduce 
and discuss new developments, protocols and guidelines 
leading to comparable quality of care in both locations. 
Comprehensive cancer centre teams working together 
over videoconferencing with a peripheral hospital team, 
reviewing radiotherapy planning align their treatment 
plans (7% major and 21% minor changes)16 and speed 
up follow- up appointments.15
The video- conferenced MDT differs from the local 
MDT: complex cases are discussed with a second ‘expert 
team’ of head- and- neck oncology specialists. The patients 
treated by the centre and partner are similar, although 
diagnostics and treatment might differ slightly,29 only in 
case of rare tumours that need skull base surgery patients 
travel from partner to centre. In our study, the significant 
differences in tumour localisation, cell type and tumour 
stage between sites are a consequence of ‘the DHCI 
requirement’, whereas the ‘centre’ could decide which 
of its patients would make an interesting case for discus-
sion. Consequently, the partner presents three to four 
times as many patients as the centre. One- third of these 
(31%) reappeared in the subsequent video conferences, 
checking extra diagnostic information, treatment plan 
and need for adjuvant therapy. Most of these presenta-
tions were seen as a ‘formality’.
The perceived value of the video- conferenced MDT 
might be influenced by the expertise of specialists. The 
recommendations given during the evaluation period 
were mostly given to ENT by an OMS oncologist who 
had considerably more clinical experience than his 
opposing colleague had, and was one of the instigators 
of the collaboration. It could be that recommendations 
given were accepted more easily if given by a more expe-
rienced specialist.12 Videoconferencing enables special-
ists acquiring experience with presenting patients with 
complex oncology and with decision- making in teams.6 17
limitations of this study
Contrary to our findings from the 4- week pilot study 
(n=46), where advice was offered in 20% of the presented 
cases, the actual 2% recommendations is much lower. 
Although it is difficult to explain this difference in 
amount of ‘agreed recommendations’, we think that the 
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pilot served mainly as a feasibility check that helped us 
to define our research questions and to operationalise 
the definitions. Other factors may also have played a role 
in the difference between the pilot and the actual study. 
First, the long- lasting collaboration between the centre 
and the partner had led to a high level of alignment on 
diagnostic and therapeutic ‘strategies’ or medical view-
points. Second, the participants were not blinded for the 
research question. Thus, awareness of being part of an 
experiment may have led to a drive to perform well and to 
present the patients with an optimal diagnostic and treat-
ment plan (Hawthorne effect). Additionally, the presence 
of the researcher might have influenced the communi-
cation between centre and partner. Often, the teams 
mentioned that the other team was asked to give collegial 
advice, and therefore, a suggestion was not always seen 
as a recommendation. This nuance could also be inter-
preted as a social desirable answer, possibly due to the 
long existing collaboration between the centre and the 
partner before study start. Third, some patient cases were 
only presented as interesting to discuss. Finally, during 
the pilot study, the advice given was not assessed for its 
impact.
In this study, we evaluated the added value of a video- 
conferenced MDT between one oncology centre and 
its preferred partner. In line with other studies,30 31 this 
study showed that, in addition to a quantitative result 
(number of recommendations), it is important to reflect 
on the situation through an interview process (quali-
tative results) before starting to implement improve-
ments. The interviews showed that specialists from 
both centre and partner support the idea of sustainable 
collaboration, but they do not support the view implicit 
in the DHCI requirement that the centre should act as 
means of quality control for the partner.32 Our find-
ings on video- conferenced MDTs find support else-
where in terms of the positive results on teams working 
together.33–35 Other studies have shown that more 
research is needed to understand the effects of video- 
conferenced MDT on patient outcomes, such as finance 
including resource usage,36 37 what fields of specialisms 
could benefit from the medium,28 38 participant satis-
faction,39 throughput times40 and self- management for 
patients.41
In summary, we believe that the DHCI requirement 
(the partner should discuss all patients with the centre) is 
unnecessary in the case of routine patients, since it does 
not add value to the quality of their treatment. It is more 
useful to spend time to discuss complex cases in greater 
detail. We propose the following measures that will add 
value to the weekly video- conferenced MDT:
1. All the participating medical specialists should be 
granted freedom to select only complex or interest-
ing cases that could serve to keep medical procedures 
aligned.
2. The partner should not be obliged to present cases 
seen as ‘routine patients’ since this does not add value.
3. The video- conferenced MDT should be organised as 
an integral part of the partners’ MDT and not as a sep-
arate weekly meeting.
4. Accepted, mature processes should be regularly re-
assessed and refocused to enable new collaboration 
strategies.
Based on our findings on the added value of the multi-
disciplinary video conference between the head- and- neck 
centre and its partner and our suggestions for improve-
ments, we would advise the DHNS, along with healthcare 
policymakers, to reconsider the DHCI requirement.
In our study, we found that there are clinical and prac-
tical implications on how and when to start with videocon-
ferencing instead of meetings with physical attendance. 
Videoconferencing must be seen as a supportive medium 
for communication within a sustainable collaboration of 
parties that understand each other’s roles and work with 
guidelines or protocols.
Participants of a video conference should:
1. Know each other and meet face- to- face on a regular 
basis, which serve cohesion (management meetings 
on governance, guideline developments and research 
projects are ideal for this purpose).
2. Respect each other as ‘expert/knowing’ colleague and 
know each other’s role in the multidisciplinary treat-
ment of patients.
3. Trust each other in follow- up of changes to diagnostic 
and treatment plans.
In view of the above- mentioned implications, we would 
not recommend starting with videoconferencing for 
multidisciplinary meetings if a majority of participants do 
not know each other.
COnClusIOns
The video- conferenced MDT has added value in the 
collaboration and in the care pathway management. 
When interpreting national multidisciplinary guidelines, 
centre and partner align their medical policies. This leads 
to a more efficient use of resources and work force.
Conversely, discussing non- complex cases is seen as a 
burden and the DHCI requirement to discuss all the part-
ners’ cases as outdated.
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